RxDoctor Payments Data

Timothy Hagemann

Interventional Cardiology · Mechanicsville, VANPI 1568489425

Payments from drug & device makers

$1,562in general payments, 2019–2025

Across 76 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$294
  • Abbott$248
  • Novartis$187
  • Boehringer Ingelheim$170
  • Amgen$165
  • Sanofi-aventis U.S. LLC$106
  • plus $392 from 15 others

What the payments were for

  • Food & beverage$1,562100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,562 in reported general payments places this provider in the 25th percentile of 176 interventional cardiology providers in Virginia.

See all interventional cardiology providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$67,404
XareltoRivaroxaban17$23,700
EntrestoSacubitril/Valsartan30$22,271
JardianceEmpagliflozin17$10,274
BrilintaTicagrelor14$6,037
Metoprolol Succinate132$1,641
Atorvastatin Calcium136$1,596
Flecainide Acetate50$1,279
Amiodarone Hcl11$665
Ezetimibe16$662
Rosuvastatin Calcium33$341
Metoprolol Tartrate40$334
Valsartan16$287
Losartan Potassium34$243
ClopidogrelClopidogrel Bisulfate43$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$53$67,40479 claims
Johnson & JohnsonXarelto$49$23,70017 claims
NovartisEntresto$187$22,27130 claims
Boehringer IngelheimJardiance$170$10,27417 claims
AstraZenecaBrilinta$27$6,03714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 176 interventional cardiology providers in Virginia.

Other interventional cardiology in Mechanicsville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →